Kang, Hyo Jin <br/><br/>
HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.  [electronic resource] 

 -  Scientific reports  Dec 2014 
 - 7201 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep07201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antioxidant Response Elements--genetics<br/>Breast Neoplasms--drug therapy<br/>Cell Line<br/>DNA-Binding Proteins--genetics<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HEK293 Cells<br/>Heme Oxygenase-1--genetics<br/>Humans<br/>MCF-7 Cells<br/>Multidrug Resistance-Associated Proteins--genetics<br/>NF-E2-Related Factor 2--genetics<br/>Paraquat--pharmacology<br/>Receptor, ErbB-2--genetics<br/>Transcription, Genetic--drug effects<br/>Transcriptional Activation--drug effects<br/>Tumor Cells, Cultured<br/>Up-Regulation--drug effects